- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Cost an Important Determinant of Adherence, CDC Reports
The CDC report found that patients on high cost prescription medications ask their physician for low-cost alternatives, but cheaper medications from outside the Unites States, skip doses, or delay refills to save cost.
Nearly one in 10 American adults don't take their medications as prescribed because they can't afford to, health officials reported Thursday.
High drug costs in the United States may be hurting the very people the medications are meant to help, the new report from the CDC suggests.
About 15% of U.S. adults have asked their doctor for a lower-cost alternative, the researchers found. Moreover, almost 2% have bought prescription drugs from another country—where medications may or may not be regulated—and more than 4% have tried alternative therapies.
Read more on MedicalXpress: http://bit.ly/1wI870Y
AI Meets Medicare: Inside CMS’s WISeR Model With Sanjay Doddamani, MD, MBA, Part 2
August 5th 2025In this second part of his interview with The American Journal of Managed Care®, Sanjay Doddamani, MD, MBA, a former senior advisor to CMMI and founder and CEO of Guidehealth, continues a dialogue on the future of value-based care and the promise—and limits—of AI-enabled innovation, reflecting on challenges like rising Medicare costs and patients’ growing financial burdens.
Read More
Trump Directs Pharma Companies on Cutting Drug Prices Under Most-Favored-Nation Order
July 31st 2025President Donald Trump has sent letters to pharmaceutical companies, aiming to compel them to lower drug prices in the US to match the lowest prices offered in other developed nations, a move that could significantly reduce costs and disrupt the current system of pharmacy benefit managers.
Read More
